Home > Financial Ratios > BAL PHARMA

BAL PHARMA
Cash Earnings per Share (CEPS)

    Back to All Ratios
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   CEPS(Rs) 11.087.499.959.60-3.68

What is the latest Cash Earnings per Share (CEPS) ratio of BAL PHARMA ?

The latest Cash Earnings per Share (CEPS) ratio of BAL PHARMA is 11.08 based on Mar2024 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar202411.08
Mar20237.49
Mar20229.95
Mar20219.60
Mar2020-3.68

How is Cash Earnings per Share (CEPS) of BAL PHARMA Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2024 11.08
47.93
Mar2023 7.49
-24.72
Mar2022 9.95
3.65
Mar2021 9.6
Positive
Mar2020 -3.68 -

Other Financial Ratios of BAL PHARMA


Compare Cash Earnings per Share (CEPS) ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹167.7 Cr -5.6% -16.7% -7.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,692.0 Cr -5.3% -7.8% 24.1% Stock Analytics
DIVIS LABORATORIES ₹149,215.0 Cr -3.9% -7.9% 51% Stock Analytics
CIPLA ₹115,000.0 Cr -1.9% -6.9% 3.6% Stock Analytics
DR REDDYS LABORATORIES ₹98,616.4 Cr -8.3% -14.9% 0.8% Stock Analytics
ZYDUS LIFESCIENCES ₹93,841.4 Cr -5.7% -4% 23.6% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-5.6%

-16.7%

-7.6%

SENSEX

0.2%

-2.2%

7.7%


You may also like the below Video Courses